Alert: New Earnings Report (5/2/24)-Alnylam Pharmaceuticals Inc (NASDAQ: ALNY).
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) has reported a loss for its first fiscal quarter (ending March 31) of $-0.52 versus a loss $-1.40 for the same period a year ago. This result was in line […]